Skip to content

Technology and startups

Page 65


From VCs to loan providers and crowdfunding platforms, those who fund startups are feeling the long-tail effects of a struggling economic environment. But at least we're seeing more transparency about it.




















It's accepted that startup employees can lose their equity if they fall afoul of bad leaver clauses or break NDAs. But there are other tripwires that threaten equity even for those who leave on good terms.






While the defence tech company has a compelling story to tell, it clearly looked wildly overvalued. And a Capital Brief story on short sellers willing to bet on that was enough to send its share price plummeting.













Sydney healthcare startup Eucalyptus is the latest company to chase a piece of the growing longevity market with a $995-a-month program called Compound.


As the market shows signs of recovery, Australian VC heavyweights signal a potential surge in Series B and beyond for the latter half of 2024, challenging perceptions of a risk-averse funding landscape.




Next page